A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus.

Fish, R, Sanders, C, Adams, R et al. (8 more authors) (2018) A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterology and Hepatology, 3 (12). pp. 865-873. ISSN 2468-1253

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier Ltd. All rights reserved. This is an author produced version of a paper published in Lancet Gastroenterology and Hepatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 23 July 2018
  • Published (online): 7 November 2018
  • Published: December 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 10 Dec 2018 10:54
Last Modified: 07 May 2019 00:40
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S2468-1253(18)30264-4
Related URLs:

Share / Export

Statistics